Helen Torley - 15 Feb 2022 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role: President and CEO, Director
Signature: /s/ James R. Oehler as attorney-in-fact for Helen Torley
Issuer symbol: HALO
Transactions as of: 15 Feb 2022
Net transactions value: -$237,292
Form type: 4
Filing time: 17 Feb 2022, 17:02:26 UTC
Previous filing: 14 Feb 2022
Next filing: 17 Nov 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HALO	Common Stock	Options Exercise	$0	+13,092	+2.3%	$0.000000	594,069	15 Feb 2022	Direct
transaction	HALO	Common Stock	Tax liability	$237,292	-6,892	-1.2%	$34.43	587,177	15 Feb 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HALO	Restricted Stock Units	Options Exercise	$0	-13,092	-25%	$0.000000	39,276	15 Feb 2022	Common Stock	13,092	$0.000000	Direct	F2
transaction	HALO	Option to Purchase Common Stock	Award	$0	+257,046		$0.000000	257,046	16 Feb 2022	Common Stock	257,046	$34.36	Direct	F3
transaction	HALO	Restricted Stock Units	Award	$0	+84,037		$0.000000	84,037	16 Feb 2022	Common Stock	84,037	$0.000000	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported disposition of 6,892 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2	This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
F3	This option vests one-fourth on such date and then 1/48th monthly thereafter.
F4	This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.